Asia Pacific Radiopharmaceuticals Market Size & Outlook

The radiopharmaceuticals market in Asia Pacific is expected to reach a projected revenue of US$ 7,648.3 million by 2030. A compound annual growth rate of 10.7% is expected of Asia Pacific radiopharmaceuticals market from 2025 to 2030.
Revenue, 2024 (US$M)
$3,832.3
Forecast, 2030 (US$M)
$7,648.3
CAGR, 2025 - 2030
10.7%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific radiopharmaceuticals market, 2018-2030 (US$M)

Asia Pacific radiopharmaceuticals market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific radiopharmaceuticals market highlights

  • The Asia Pacific radiopharmaceuticals market generated a revenue of USD 3,832.3 million in 2024.
  • The market is expected to grow at a CAGR of 10.7% from 2025 to 2030.
  • In terms of segment, diagnostics was the largest revenue generating product in 2024.
  • Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 3,832.3 million
Market revenue in 2030USD 7,648.3 million
Growth rate10.7% (CAGR from 2025 to 2030)
Largest segmentDiagnostics
Fastest growing segmentDiagnostics
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics, Therapeutics

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 21.6% of the global radiopharmaceuticals market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 7,648.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiopharmaceuticals Market Companies

Name Profile # Employees HQ Website

Asia Pacific radiopharmaceuticals market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiopharmaceuticals market will help companies and investors design strategic landscapes.


Diagnostics was the largest segment with a revenue share of 92.31% in 2024. Horizon Databook has segmented the Asia Pacific radiopharmaceuticals market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.


  • Asia Pacific Radiopharmaceuticals Product Outlook (Revenue, USD Million, 2018-2030)
    • Diagnostics
      • SPECT
        • TC-99m
        • TL-201
        • GA-67
        • I-123
        • Others
      • PET
        • F-18
        • SR-82/RB-82
        • PYLARIFY (piflufolastat F 18)
        • Illuccix (gallium Ga 68 gozetotide)
        • Others
    • Therapeutics
      • Alpha Emitters
        • RA-223
        • Others
      • Beta Emitters
        • I-131
        • Y-90
        • SM-153
        • Re-186
        • Lu-177
        • Others
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Palladium-103
        • Iridium-192
        • Others
  • Asia Pacific Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2018-2030)
    • Neurology
    • Oncology
    • Lymphoma
    • Endocrine Tumor
    • Pulmonary Scans
    • Urology
    • Other
    • Cardiology
      • SPECT
      • PET
      • Therapeutic Applications
    • Thyroid
      • SPECT
      • Therapeutic Applications
    • Bone Metastasis
      • SPECT
      • Therapeutic Applications
  • Asia Pacific Radiopharmaceuticals End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • Diagnostic Centers
    • Others

Reasons to subscribe to Asia Pacific radiopharmaceuticals market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific radiopharmaceuticals market databook

  • Our clientele includes a mix of radiopharmaceuticals market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific radiopharmaceuticals market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific radiopharmaceuticals market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific radiopharmaceuticals market size, by country, 2018-2030 (US$M)

Asia Pacific Radiopharmaceuticals Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific radiopharmaceuticals market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online